Compare · TMO vs VLD
TMO vs VLD
Side-by-side comparison of Thermo Fisher Scientific Inc (TMO) and Velo3D Inc. (VLD): market cap, price performance, sector, and recent activity on the wire.
Summary
- TMO operates in Industrials, while VLD operates in Technology - the two are in different parts of the market.
- TMO is the larger of the two at $175.70B, about 164.8x VLD ($1.07B).
- TMO has hit the wire 17 times in the past 4 weeks while VLD has been quiet.
- TMO has more recent analyst coverage (25 ratings vs 4 for VLD).
- Company
- Thermo Fisher Scientific Inc
- Velo3D Inc.
- Price
- $472.68-0.01%
- $1.25-5.30%
- Market cap
- $175.70B
- $1.07B
- 1M return
- -0.38%
- -
- 1Y return
- +15.66%
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- News (4w)
- 17
- 0
- Recent ratings
- 25
- 4
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Velo3D Inc.
Velo3D, Inc. produces metal additive three dimensional printers. The company's printers enable the production of components for space rockets, jet engines, fuel delivery systems, and other high value metal parts, which it sells or leases to customers for use in their businesses. It offers Flow, a proprietary software platform, which scans part designs for geometrical features; Sapphire and Sapphire XC printers; and Assure, a quality control system software platform that includes closed loop process metrologies. The company also provides support services. Its customers range from small- and medium-sized enterprises to Fortune 500 companies in the space, aviation, defense, energy, and industrial markets. Velo3D, Inc. was founded in 2014 and is headquartered in Campbell, California.
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)
Latest VLD
- CEO Kreger Bradley Allen converted options into 898 shares and sold $163 worth of shares (363 units at $0.45), increasing direct ownership by 6% to 9,341 units (SEC Form 4)
- Velo3D Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Director Smith Ellen was granted 1,423 shares, increasing direct ownership by 8% to 18,440 units (SEC Form 4)
- Director Bass Carl was granted 1,423 shares, increasing direct ownership by 6% to 24,146 units (SEC Form 4)
- Director Toledano Gabrielle B was granted 1,423 shares, increasing direct ownership by 14% to 11,775 units (SEC Form 4)
- Director Walters Matthew Joseph was granted 1,423 shares, increasing direct ownership by 5% to 31,863 units (SEC Form 4)
- Director Idelchik Michael was granted 1,423 shares, increasing direct ownership by 16% to 10,221 units (SEC Form 4)
- Director Keppler Adrian was granted 1,423 shares, increasing direct ownership by 19% to 8,845 units (SEC Form 4)
- Director Krause Stefan was granted 1,423 shares, increasing direct ownership by 14% to 11,260 units (SEC Form 4)
- Director Buller Benyamin was granted 1,423 shares, increasing direct ownership by 0.95% to 150,783 units (SEC Form 4)